Insufficient scRNA-seq data for expression of NEU2 at single-cell level.
Insufficient scRNA-seq data for expression of NEU2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 65% | 70.46 | 1171 / 1809 | 4% | 0.14 | 18 / 472 |
esophagus | 0% | 0 | 0 / 1445 | 6% | 0.37 | 11 / 183 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.08 | 1 / 45 |
ovary | 0% | 0 | 0 / 180 | 2% | 0.04 | 9 / 430 |
uterus | 0% | 0 | 0 / 170 | 2% | 0.06 | 7 / 459 |
intestine | 0% | 0 | 0 / 966 | 1% | 0.01 | 4 / 527 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.03 | 3 / 504 |
lung | 0% | 0 | 0 / 578 | 1% | 0.01 | 6 / 1155 |
stomach | 0% | 0 | 0 / 359 | 0% | 0.01 | 1 / 286 |
adipose | 0% | 0.77 | 3 / 1204 | 0% | 0 | 0 / 0 |
brain | 0% | 0.02 | 3 / 2642 | 0% | 0 | 0 / 705 |
blood vessel | 0% | 0.02 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
breast | 0% | 0 | 0 / 459 | 0% | 0 | 0 / 1118 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 0% | 0 | 0 / 178 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
thymus | 0% | 0 | 0 / 653 | 0% | 0 | 0 / 605 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009313 | Biological process | oligosaccharide catabolic process |
GO_0006516 | Biological process | glycoprotein catabolic process |
GO_0006689 | Biological process | ganglioside catabolic process |
GO_0046479 | Biological process | glycosphingolipid catabolic process |
GO_0005764 | Cellular component | lysosome |
GO_1902494 | Cellular component | catalytic complex |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0052796 | Molecular function | exo-alpha-(2->8)-sialidase activity |
GO_0052794 | Molecular function | exo-alpha-(2->3)-sialidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0052795 | Molecular function | exo-alpha-(2->6)-sialidase activity |
GO_0004308 | Molecular function | exo-alpha-sialidase activity |
Gene name | NEU2 |
Protein name | Sialidase-2 (EC 3.2.1.18) (Cytosolic sialidase) (N-acetyl-alpha-neuraminidase 2) |
Synonyms | |
Description | FUNCTION: Exo-alpha-sialidase that catalyzes the hydrolytic cleavage of the terminal sialic acid (N-acetylneuraminic acid, Neu5Ac) of a glycan moiety in the catabolism of glycolipids, glycoproteins and oligosacharides . Recognizes sialyl linkage positions of the glycan moiety as well as the supramolecular organization of the sialoglycoconjugate. Displays preference for alpha-(2->3)-sialylated GD1a and GT1B gangliosides over alpha-(2->8)-sialylated GD1b, in both monomeric forms and micelles. Hydrolyzes monomeric GM1 ganglioside, but has no activity toward the miscellar form . Has lower sialidase activity for glycoproteins such as fetuin and TF/transferrin that carry a mixture of alpha-(2->3) and alpha-(2->6)-sialyl linkages. Cleaves milk oligosaccharide alpha-(2->3)-sialyllactose, but is inactive toward alpha-(2->6)-sialyllactose isomer. Has no activity toward colominic acid, a homomer of alpha-(2->8)-linked Neu5Ac residues . . |
Accessions | ENST00000233840.3 Q9Y3R4 |